Top Vaccines companies in Switzerland by Price to Sales Ratio (P/S)
Switzerland
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
21.98 |
Feb. 5, 2025 | USD 4.99 | 1.08% |
|
Switzerland |
|
| 2 |
2.92 |
Feb. 5, 2025 | USD 45.08 | 2.29% |
|
Switzerland |
|
| 3 |
2.47 |
Feb. 5, 2025 | USD 26.45 | -1.05% |
|
Switzerland |
|
| 4 |
2.12 |
Feb. 5, 2025 | USD 48.28 | 3.35% |
|
Switzerland |
Frequently Asked Questions
-
Which Vaccines company in Switzerland has the highest Price to Sales Ratio (P/S) ?
The Vaccines company in Switzerland with the highest Price to Sales Ratio (P/S) is Molecular Partners AG (Swiss Stock Exchange: MOLN.SW) at 21.98.
-
Which Vaccines company in Switzerland has the lowest Price to Sales Ratio (P/S) ?
The Vaccines company in Switzerland with the lowest Price to Sales Ratio (P/S) is Sandoz Group AG (Swiss Stock Exchange: SDZ.SW) at 2.12.
-
What are the top 10 Vaccines companies in Switzerland by Price to Sales Ratio (P/S) ?
The top 10 Vaccines companies in Switzerland by Price to Sales Ratio (P/S) are Molecular Partners AG, Basilea Pharmaceutica AG, PolyPeptide Group AG and Sandoz Group AG.
-
What are the bottom 10 Vaccines companies in Switzerland by Price to Sales Ratio (P/S) ?
The bottom 10 Vaccines companies in Switzerland by Price to Sales Ratio (P/S) are Sandoz Group AG, PolyPeptide Group AG, Basilea Pharmaceutica AG and Molecular Partners AG.
